Vol 44, No 4 (2013)
Prace poglądowe / Reviews
Published online: 2013-10-01
Immunomodulatory drugs – landmark in the therapy of haematological malignancies
DOI: 10.1016/j.achaem.2013.06.003
Acta Haematol Pol 2013;44(4):370-377.
Abstract
Introduction of new drugs into therapy of multiple myeloma prolonged significantly progression free survival and overall survival of patients. Taking into account pleiotropic effects of these drugs it was shown that immunomodulatory drugs are very effective in other haematological malignancies such as lymphomas, myelodysplastic syndromes, leukemias or chronic myeloproliferative diseases.
Keywords: Immunomodulatory drugsMultiple myelomaMyelodysplastic syndromesNon-Hogdkins’ lymphomasChronic lymphocytic leukaemia